Introduction 23
A period of prolonged (i.e. several weeks) muscle disuse, due to illness or injury, can lead to substantial 24 loss of skeletal muscle mass and strength in otherwise healthy individuals. The resulting negative health 25 consequences, such as impaired functional capacity (1-3), decreased muscle strength (4), the onset of insulin 26 resistance (5), and a decline in basal metabolic rate (6, 7) , are of particular concern to elderly individuals, 27 who are already functionally and/or metabolically compromised. Recently, we (8, 9) as well as others (10) 28 have shown that even a few days of disuse can already lead to significant losses of muscle mass and strength 29 in young and old men. These findings are of particular clinical relevance as hospitalization of elderly due 30 to acute illness generally results in an average 5-7 day hospital stay (11) . It has been hypothesized that such 31 short successive periods of muscle disuse occurring throughout the lifespan may be instrumental in the 32 progressive loss of muscle mass that occurs with aging (12, 13) . 33
Any substantial loss of skeletal muscle mass due to muscle disuse must be attributed to a chronic imbalance 34 between muscle protein synthesis and breakdown rates. A decline in basal (post-absorptive) muscle protein 35 synthesis rates has been reported following both bed-rest (14-16) as well as limb immobilization (17) (18) (19) . 36
Furthermore, recent work from our laboratory (20) as well as others (17, 21, 22) has shown that the muscle 37 protein synthetic response to protein or amino acid administration becomes blunted following a period of 38 disuse. Additionally, there is some indirect evidence that increases in muscle protein breakdown rates occur 39 during the initial first few days of muscle disuse only (23) (24) (25) . As such, it is now widely thought that 40 declines in both post-absorptive and post-prandial muscle protein synthesis rates play the major causal role 41 in the loss of muscle mass during a period of disuse (26, 27) . Dietary protein intake stimulates muscle 42 protein synthesis rates and inhibits muscle protein breakdown, and thereby allows net muscle protein 43 accretion (28) . Accordingly, it has been speculated that maintaining or even increasing dietary protein 44 intake can attenuate muscle loss during a period of disuse (12, 27) . In support, intervention studies have 45
shown high-dose, essential amino acid supplementation to attenuate muscle loss during prolonged bed-rest 46 in young (29) (30) (31) and elderly individuals (32) . However, the potential for a practical dietary protein feeding 47 strategy to alleviate muscle loss during short-term disuse in the elderly population remains to be 48
investigated. 49
In the present study, we investigated our hypothesis that dietary protein supplementation attenuates muscle 50 loss during a short period of muscle disuse in older men. To test this hypothesis, 23 healthy elderly men 51 were selected to participate in a study during which they were subjected to 5 days of one-legged knee 52 immobilization with or without dietary protein supplementation (~20 g protein twice daily). Muscle mass 53 and strength were assessed prior to and immediately after immobilization, and muscle biopsy samples were 54 collected to assess muscle fiber characteristics and associated myocellular signaling. 55
Methods 57
prior to muscle biopsy collection. Percutaneous muscle biopsies were taken from m. vastus lateralis with 109 the Bergstrom technique, approximately 15 cm above the patella. The collected muscle was freed from any 110 visible non-muscle tissue, processed immediately, and stored at -80°C until further analysis. 111
Leg immobilization 113
Two days after performing test day 1, at 8:00 in the morning, a full leg cast (randomized and 114 counterbalanced for left and right leg) was applied in the casting room of the Academic Hospital in 115
Maastricht. This marked the start of the 5 day immobilization period that always contained 3 week days 116 and 2 weekend days. The cast extended from ~5 cm above the ankle until ~25 cm above the patella. A ~30 117 degree angle of flexion of the knee joint was established in order to prevent subjects from performing 118 weight-bearing activities with the immobilized leg. Subjects received crutches and were instructed on the 119 correct usage before being provided with transportation home. The cast was removed at 8:00 on the morning 120 of test day 2, after exactly 5 days of immobilization. 121
Protein supplementation 123
Subjects were randomly allocated to the group receiving a high whey protein leucine-enriched oral 124 nutritional supplement (PRO) or the control group receiving no supplement (CON). Subjects allocated to 125 the PRO group consumed the first drink in the laboratory on the morning of casting and were instructed to 126 consume one drink directly after breakfast and one drink immediately prior to sleep on each day during 127 immobilization (i.e. twice-daily, 10 drinks in total). Each drink provided 635 kJ, 21 g protein, 9 g 128 carbohydrates, 3 g fat, and a mixture of vitamins, minerals and fibers. Supplemental Table 1 
Muscle analysis 140
Muscle samples were freed from any visible non-muscle tissue and separated into two sections. The first 141 part (~30 mg) was imbedded in Tissue-Tek (Sakura Finetek, Zoeterwoude, the Netherlands), frozen on 142 liquid nitrogen cooled isopentane and used to determine muscle fiber-type specific cross-sectional area 143 (CSA) and satellite cell content as done previously (8) . The second part (~15 mg) was snap frozen in liquid 144 nitrogen and used for real time-PCR analysis to determine mRNA expression of selected genes as described 145 before (8, 20) . A detailed overview of the muscle analyses is presented in the online supporting material. 146
147

Statistics 148
All data are expressed as mean±SEM. Baseline values between groups were compared by means of an 149 independent samples t-test. Pre-versus post-immobilization data were analyzed using Repeated Measures 150 ANOVA with treatment (CON vs PRO) as between-subjects factor and time (pre-vs post-immobilization) 151 as within-subjects factor. Fiber type (type I vs type II) was added to the test as a within-subjects factor when 152 performing the statistical analyses for the muscle data. In case of a significant main effect, paired-samples 153 t tests were executed to determine time effects within treatment groups or within fiber types, and 154 independent-samples t tests were performed to determine group differences in pre-and post-immobilization 155 values. When a significant main effect was detected, Bonferroni's post hoc test was applied to locate the 156 differences. A P-value of <0.05 was used to determine statistical significance. All data were analyzed using 157 SPSS version 20.0 (SPSS Inc., Chicago, IL, USA). 158
Results
160
Subjects 161
Subjects' characteristics are provided in Table 1 . No baseline differences between the control (CON) and 162 protein (PRO) groups were observed for age, height, weight, BMI, glucose, insulin, HOMA, or HbA1c 163 levels at baseline. Glucose, insulin, and HOMA were measured pre-and post-intervention, and did not 164 change over time in either group. 165
166
Muscle mass and strength 167
Quadriceps muscle cross-sectional area (CSA) is displayed in Figure 2A . At baseline, no differences were 168 observed in quadriceps or whole leg muscle CSA between groups (P>0.05 for both parameters). Five days 169 of immobilization caused significant muscle atrophy of the quadriceps (time effect, P<0.001; see Figure  170 2A) and the whole leg (time effect, P<0.05; from 13.3±5.4 to 13.2±5.3 cm 2 (-0.7±0.6%) in CON and from 171 12.6±4.2 to 12.4±4.6 cm 2 (-1.6±0.6%) in PRO) with no differences between groups (P-interaction>0.05 for 172 both parameters). Immobilization did not affect whole-body or leg lean mass in either group (data not 173
shown; both P>0.05). Leg muscle strength data are presented in Figure 2B . Maximal leg muscle strength 174 had decreased following immobilization in the CON and PRO group (time effect, P<0.001), with no 175 differences between groups (P-interaction>0.05). 176
177
Dietary intake 178 Table 2 shows data for subjects' habitual diet for 5 days under free living conditions and during the 5 day 179 immobilization period. No differences in habitual diet were observed between groups (all measured 180 parameters P>0.05). Habitual diet did not change due to immobilization in the CON group (P>0.05), 181 whereas in the PRO group, twice-daily ingestion of the protein drink significantly increased protein intake 182
(expressed as g·day -1 , g·kg -1 ·day -1 , and En%) compared with baseline (P<0.05) and the CON group 183 (P<0.05). Habitual protein intake averaged 1.1 g·kg -1 ·day -1 and was increased to 1.6 g·kg -1 ·day -1 during the 184 immobilization period in the PRO group. Energy intake in the PRO group was maintained during 185 immobilization; a relatively higher amount of energy was received from protein, at the expense of energy 186 from fat (P<0.05). 187
Plasma analyses 189
Plasma amino acid concentrations (Supplemental Table 2 
Muscle fiber characteristics 198
Muscle fiber characteristics are displayed in Table 3 . At baseline, no differences between groups were 199 Figure 1D) and PAT1 (Supplemental Figure 1E) , a 217 significant time effect was found (P<0.01 for both genes) such that expression was upregulated following 218 immobilization in both groups. All other genes showed no significant changes between or within groups. 219
Discussion 220
In the present study, we demonstrate that merely 5 days of one-legged knee immobilization leads to 221 substantial skeletal muscle mass and strength loss in healthy, elderly men. Increasing dietary protein intake 222 by supplementing ~20 g protein twice-daily did not attenuate the loss of muscle mass or strength during 5 223 days of muscle disuse in older males. 224
A period of prolonged muscle disuse and the associated muscle atrophy causes numerous negative health 225 consequences (1, 2, 4, 6) , and the occurrence of successive periods of muscle disuse likely represents a key 226 factor responsible for the loss of muscle mass during the later decades of our lifespan (13) . In the present 227 study, we report that only 5 days of muscle disuse already leads to substantial loss of muscle mass (-228 1.5±0.7%; Figure 2A ) and strength (-8.3±3.3%; Figure 2B ) in older individuals. These data are in line with 229 recent data from our group in which we observed similar muscle mass and strength losses in younger 230 individuals (8). Furthermore, Suetta et al. reported significant muscle fiber atrophy after 4 days of 231 immobilization in both young and older individuals (10) . The rapid muscle atrophy observed in our older 232 subjects after merely 5 days of leg immobilization is of important clinical significance, as successive short 233 periods of muscle disuse due to illness or injury are highly prevalent during the later stages of our lifespan 234 (36). In line, the average length of hospitalization for elderly patients admitted with acute illness is 5-7 235 days (11). The observed muscle loss is of particular relevance as the older population has difficulty to regain 236 skeletal muscle mass and strength following a period of disuse (37) . Even when applying rehabilitative 237 resistance-type exercise training after a period of disuse, muscle mass does not seem to be restored after 4 238 weeks of intense supervised training (37) . For these reasons, it is presently believed that the impact of short 239 successive episodes of muscle disuse may be of key relevance in the development of sarcopenia (13) . 240
Practical and effective interventional strategies are needed to prevent or attenuate muscle mass and strength 241 loss during short periods of muscle disuse in healthy elderly as well as more clinically compromised 242 subpopulations. It has been proposed that simply increasing the protein content of the diet may alleviate the 243 loss of muscle tissue during a period of disuse (12, 27) . Indeed, studies focusing on mimicking prolonged 244 hospitalization (i.e. >2-3 weeks bed-rest under tightly controlled dietary conditions) have shown that 245 supplementation with high doses of crystalline essential amino acids (~50 g, equivalent to ~100-150 g intact 246 protein) attenuates the loss of muscle mass (29) (30) (31) . Given the clinical relevance of short, successive periods 247 of muscle disuse, we assessed the efficacy of a more practical and feasible dietary strategy to attenuate 248 muscle loss during a short period of limb immobilization under free living conditions. Increasing dietary 249 protein intake from 1.1 to 1.6 g·kg body weight -1 ·day -1 did not rescue the loss of muscle mass or strength 250 observed during a 5 day period of leg immobilization (Figure 2) . The apparent discrepancy between the 251 outcome of the present study and previous work in prolonged bed rest studies may be attributed to 252 differences in protein intake in the control group. In the present study the control group retained normal 253 habitual energy and protein intake (1.1 g·kg -1 ·day -1 ) whereas the protein group received additional 254 supplementation (1.6 g·kg -1 ·day -1 ). In contrast, in previous bed rest studies that show benefits of amino acid 255 supplementation on muscle mass maintenance, the control groups generally consumed dietary protein at a 256 level no higher than 0.8 g·kg -1 ·day -1 (29) (30) (31) . Consequently, we speculate that maintaining dietary protein 257 intake is required to prevent muscle loss during disuse, but that increasing dietary protein intake above 258 habitual levels does not further alleviate muscle loss during disuse (38, 39) . This would be of particular 259 relevance in institutionalized or hospitalized elderly who are unable to maintain habitual dietary protein 260 consumption during more prolonged periods of muscle disuse due to illness or injury. Additional 261 considerations of the present nutritional intervention include the type and timing of protein administered. 262
We selected whey protein in the present study as we have previously shown it leads to greater post-prandial 263 muscle protein accretion compared with casein protein in healthy elderly men (40) . We chose to supplement 264 volunteers at breakfast time since we have previously shown that community dwelling elderly individuals 265 generally consume inadequate amounts of protein at breakfast (41) . Specifically, the supplement was 266 consumed directly after breakfast to avoid volunteers compensating for the supplement by consuming less 267 breakfast and therefore ensuring adequate protein was consumed. This was achieved given that the PRO 268 group consumed (36±2 g at this meal compared to the CON group who only consumed 13±1 g, the latter 269 being an amount insufficient to properly stimulate muscle protein synthesis rates (42) . We opted to deliver 270 the second supplement immediately prior to sleep, since we have recently shown that such a strategy 271 effectively stimulates overnight muscle protein synthesis rates (43) . However, it is also true that these 272 beneficial effects on nocturnal muscle protein synthesis were obtained with the ingestion (or intragastric 273 administration) of large amounts of casein protein, to ensure a more sustained hyperaminoacidemia 274 throughout the night (44) . Accordingly, it could be speculated that future nutritional strategies aimed at 275 attenuating muscle disuse atrophy may wish to consider incorporating large boluses of casein as a pre-276 bedtime meal. In contrast, it could also be hypothesized that ingestion of a large bolus of dietary protein 277 prior to sleep increases both muscle protein synthesis and breakdown rates, without net muscle protein 278 accretion (45) . Though previous work has shown improvements in overnight whole-body protein balance 279 following protein administration in healthy older men (43) and in young adults during overnight recovery 280 from exercise (46), we cannot exclude that such improvements in overnight protein balance may not occur 281 in a setting of muscle disuse. 282
Besides assessing the impact of protein supplementation on muscle mass and strength during short-term 283 disuse, we wished to gain insight into the underlying myocellular mechanisms involved in muscle disuse 284 atrophy and/or muscle mass maintenance. Muscle loss during short-term muscle disuse is thought to be, at 285 least partly, mediated by accelerated rates of muscle protein breakdown (13) . Myostatin is known as a 286 negative regulator of muscle growth in vivo (47) , and acts through multiple pathways including the 287 stimulation of muscle protein breakdown (48) . Consistent with this role, we observed increases in myostatin 288 mRNA expression (Figure 3 ) and in markers of muscle protein breakdown (i.e. increased gene expression 289 of MAFBx and MuRF1; Figure 3 ). This is in line with previous findings (10) and our own work in young 290 men (8, 9) , and supportive of a role for muscle protein breakdown in short-term muscle atrophy, possibly 291 mediated through increased myostatin transcription. Given the lack of effect of protein supplementation on 292 muscle mass in the present study, it is not surprising that we observed no attenuation of the rise in myostatin 293 and markers of proteolysis. In fact, we actually observed that MAFBx and MuRF1 gene expression 294 increased to a greater extent in the PRO group (Figure 3) , supporting the idea that increasing dietary protein 295 intake beyond the habitual dietary protein intake level may strongly stimulate overall protein turnover rates. 296
Myostatin is also reported to regulate muscle size by acting via the inhibition of myogenesis through its 297 inhibitory action on the myogenic regulatory factors (49) . However, in line with our previous work (8, 50) , 298
we report that the disuse-induced increase in myostatin expression does not coincide with impaired 299 expression of the myogenic regulatory factors (i.e . MyoD and myogenin, Figure 3) . Moreover, no 300 alterations in muscle satellite cell content were observed, suggesting that the mechanisms underlying short-301 term disuse atrophy do not require alterations in myogenesis or satellite cell content. Recent data have 302 suggested that the expression of specific amino acid transporters within skeletal muscle provide a site of 303 regulation for muscle protein synthesis (51) . As such, we analyzed the gene expression of Large Neutral 304
Amino Acid Transporter 1 (LAT1/SLC) and Proton-coupled amino acid transporter 1 (PAT1) which are 305 thought to be the key transporters facilitating intramuscular transport of BCAAs particularly in response to 306 nutrition (52) . Interestingly, LAT1 and PAT1 mRNA expression (Supplemental Figure 1) increased 307 following immobilization in both groups, possibly indicating a compensatory mechanism by which 308 atrophying muscle attempts to 'scavenge' circulating amino acids as a substrate for muscle protein 309
synthesis. 310
In the present study we show that protein supplementation on top of a diet containing ample protein (1.1 311 g·kg -1 ·day -1 ) does not alleviate muscle loss during short-term single leg disuse. This shows that besides 312 maintaining dietary protein intake, other strategies are warranted to help maintain muscle mass. Where 313 possible, performing some degree of exercise should be considered during disuse (39) . In conditions where 314 exercise is not feasible due to injury or illness, low-volume physical activity (53) or even exercise surrogates 315 (8) could be suggested. Furthermore, other nutritional compounds, such as creatine or omega-3 fatty acids, 316 may support muscle maintenance during disuse (27) . An often under-appreciated consideration is how 317 dietary strategies could support rehabilitation following a period of disuse. This area has been 318 comparatively under studied (54-57) but, given the opportunity to combine nutrition with re-ambulation 319 and/or physical exercise, future research should address how dietary protein and/or other nutritional 320 strategies could best be used to facilitate the rapid and complete restoration of muscle mass following a 321 period of disuse. 322
In short, we conclude that short-term muscle disuse results in a substantial decline in both muscle mass and 323 strength in older individuals. Increasing dietary protein intake during short-term muscle disuse on top of a 324 diet providing >1.0 g·kg -1 ·day -1 does not alleviate muscle disuse atrophy in healthy, elderly men. 325
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The study was performed at Maastricht University, Maastricht, the Netherlands. The part of the muscle that was directly frozen in liquid nitrogen was used to determine mRNA expression of several genes of interest. Total RNA was isolated by using Tri Reagent (Sigma-Aldrich) on 10-20 mg of frozen muscle, according to the manufacturer's protocol. Quantification of total RNA was carried out spectrophotometrically at 260 nm (NanoDrop ND-1000 Spectrophotometer, Thermo Fisher Scientific, USA), and RNA purity was determined as the ratio of readings at 260/280 nm. Subsequently, first strand cDNA was synthesized from 1 μg RNA sample using random primers (Promega) and PowerScript Reverse Transcriptase (AppliedBiosystems, USA). Taqman PCR was carried out using an ABI Prism 7000 sequence detector (AppliedBiosystems, USA), with 2 μL of cDNA, 18 μl . L -1 of each primer, 5 μl . L -1 probe, and Universal Taqman 2 × PCR mastermix (Eurogentec) in a final volume of 25 μL. Each sample was run in duplicate, in duplex reactions, with a separate standard curve included for each gene (serial dilutions of cDNA synthesized in parallel with the study sample). 18S was used as a housekeeping gene as an internal control, and similarly to previous human immobilization studies (8, 20) it seemed unaffected by treatment 
